Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P508: Association between clinical outcome and post induction CT-P13 trough levels at week 14, in patients with inflammatory bowel disease. Preliminary results in an observational multicentric studyECCO '17 Barcelona
Year: 2017
Authors:

Elosua González A.*1, Oyόn Lara D.1, Nantes Castillejo Ó.1, Ogueta Fernández M.Ά.2, Gutiérrez Mendizábal P.3, Muñoz Villafranca M.C.3, Gόmez Irwin L.4, Muñagorri Santos A.I.5, Rodríguez Lago I.6, Rodríguez Gutiérrez C.1 IBD Study Group from the Basque-Navarre Society of Gastrointestinal Diseases

1Complejo Hospitalario de Navarra, Gastroenterology, Pamplona, Spain 2Hospital Universitario Araba, Gastroenterology, Vitoria, Spain 3Hospital Universitario Basurto, Gastroenterology, Bilbao, Spain 4Hospital Universitario Cruces, Gastroenterology, Barakaldo, Spain 5Hospital Universitario Donostia, Gastroenterology, San Sebastián, Spain 6Hospital Galdakao-Usansolo, Gastroenterology, Usansolo, Spain

P509: IBD cancer and serious infections in Europe (I-CARE): a European prospective observational studyECCO '17 Barcelona
Year: 2017
Authors:

The I-CARE Study Group

P510: Assessment of study group – patients with inflammatory bowel disease, treated with monoclonal anti-TNF alpha: a multicenter, prospective cohort observational study, Satimos – preliminary report in pediatric populationECCO '17 Barcelona
Year: 2017
Authors:

Jarzebicka D.*1, Sieczkowska J.1, Borys-Iwanicka A.2, Korlatowicz-Bilar A.3, Szaflarska-Popławska A.4, Grzybowska-Chlebowczyk U.5, Łazowska-Przeorek I.6, Daniluk U.7, Korczowski B.8, Sordyl B.9, Szczepanik M.10, Landowski P.11, Plocek A.12, Bąk-Drabik K.13, Zagόrowicz E.14, Kierkus J.1

1The Children's Memorial Health Institute, Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, Warsaw, Poland 2Independent Clinical Public Hospital No. 1, Department of Pediatrics, Gastroenterology and Nutrition, Wrocław, Poland 3Specialist Independent Public Health Care Centre for Children and Youth, Department of Pediatrics, Gastroenterology and Rheumatology, Szczecin, Poland 4University Hospital, Department of Pediatrics, Allergology and Gastroenterology, Bydgoszcz, Poland 5The Independent Public Clinical Hospital no. 6 of the Medical University of Silesia in Katowice John Paul II Upper Silesian Child Health Centre, w Katowicach Gόrnośląskie Centrum Zdrowia Dziecka im. Jana Pawła II Department of Gastroenterology, Katowice, Poland 6Independent Public Children's Hospital, Department of Gastroenterology and Nutrition, Children, Warsaw, Poland 7University Hospital, Department of Pediatrics, Gastroenterology and Allergology, Białystok, Poland 8Regional Clinical Hospital No. 2, Department of Pediatric Gastroenterology, Rzeszόw, Poland 9Polish Mother's Memorial Hospital Research Institute, Department of Gastroenterology, Allergy and Pediatrics, Łόdź, Poland 10Clinical Hospital of Medical University, Department of Gastroenterology and Metabolic Diseases, Poznań, Poland 11University Clinical Center - University Hospital, Department of Gastroenterology, Gdańsk, Poland 12Central Hospital of Medical University, Department of Allergology, Gastroenterology and Nutrition, Children, Łόdź, Poland 13Independent Public Clinical Hospital No. 1 of Silesian Medical University, Department of Pediatric, Zabrze, Poland 14Oncology Centre - Institute for them. Maria Skłodowska – Curie, Department of Gastroenterology Oncology, Warsaw, Poland

P511: Baseline characteristics of ulcerative colitis patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (01)ECCO '17 Barcelona
Year: 2017
Authors:

Wolf D.*1, Lewis J.D.2, Siegmund B.3, Lichtenstein G.2, Sebastian S.4, Siegel C.A.5, Louis E.6, Haas T.7, Nedd K.8, Subramanian S.9, Aguilar H.10, Egan L.11, Gasche C.12, Doherty G.13, Lobo A.14, Spearman D.15, Patel A.16, Moparty R.17, Brookes M.18, Hebuterne X.19, Moum B.20, Dolin P.21

1Atlanta Gastroenterology Associates, Atlanta, United States 2University of Pennsylvania Perelman School of Medicine, Division of Gastroenterology, Philadelphia, United States 3Charité - University Hospital Berlin, Campus Benjamin Franklin, Department of Gastroenterology, Berlin, Germany 4Hull Royal Infirmary, Hull & East Yorkshire Hospitals NHS Trust, Department of Gastroenterology and Hepatology, Hull, United Kingdom 5Dartmouth-Hitchcock Medical Center, Departmnet of Gastroenterology, Lebanon, United States 6CHU Liège, Liège, Belgium 7Darm Praxis Salzburg, Salzburg, Austria 8Infusion Associates, Grand Rapids, United States 9Royal Liverpool University Teaching Hospital, Department of Gastroenterology, Liverpool, United Kingdom 10Shreveport Endoscopy Center, Shreveport, LA, United States 11NUI Galway, Department of Gastroenterology, Galway, Ireland 12Medical University of Vienna, Wien, Austria 13St Vincent's University Hospital, Center for Colorectal Disease, Dublin, Ireland 14Sheffield Teaching Hospitals NHS Foundation Trust, Department of Gastroenterology, Sheffield, United Kingdom 15San Antonio Military Medical Center, San Antonio, TX, United States 16Medical College of Wisconsin, Milwaukee, United States 17Spring Gastroenterology, Humble, TX, United States 18The Royal Wolverhampton Hospital NHS, New Cross Hospital, Department of Gastroenterology, Wolverhampton, United Kingdom 19CHU Archet 2, Department of Gastroenterology, Nice, France 20Oslo University, Department of Gastroenterology, Oslo, Norway 21Takeda Development Centre Europe, Pharmacoepidemiology, London, United Kingdom

P512: Real world use of adalimumab: effects on corticosteroid treatment and hospital resource utilisation in UK patients with moderate/severe ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Watts G.*1, Arasaradnam R.2, Travis S.3, Sharma A.4, Awasthi A.5, Limdi J.6, Bishop-Bailey A.7, Mclain-Smith S.7, Finney-Hayward T.8

1University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom 2University Hospitals Coventry & Warwick NHS Trust, Coventry & Warwick, United Kingdom 3Oxford University Hospitals NHS Trust, Oxford, United Kingdom 4Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, United Kingdom 5Walsall Healthcare NHS Trust, Walsall, United Kingdom 6The Pennine Acute Hospitals NHS Trust, Crumpsall, United Kingdom 7pH Associates, Marlow, United Kingdom 8AbbVie, UK, Maidenhead, United Kingdom

P513: Managing IBD patients on adalimumab based on trough levels and antibodiesECCO '17 Barcelona
Year: 2017
Authors:

Parisi I., Atherton R., McCartney S., Vega R., Mehta S., Whitley L., Kabir M., Kiparissi F., Bloom S.

University College London Hospital, Department of Gastroenterology, London, United Kingdom

P514: Combination treatment with vedolizumab and anti-TNF-α in inflammatory bowel disease: safety dataECCO '17 Barcelona
Year: 2017
Authors:

Buer L.*1,2, Høivik M.L.1, Medhus A.W.1, Moum B.1,2

1Oslo University Hospital, Department of Gastroenterology, Oslo, Norway 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway

P515: Evaluation of treatment persistence of vedolizumab among Finnish inflammatory bowel disease patients in real-life clinical practice (FINVEDO)ECCO '17 Barcelona
Year: 2017
Authors:

Ylisaukko-oja T.1,2,3, Eberl A.*4, Aaltonen J.1, Nuutinen H.5, Blomster T.6, Jussila A.7, Pajala M.8, Jokelainen J.2,3, Herrala S.3, Tamminen K.1, Sipponen T.4

1Takeda Oy, Helsinki, Finland 2University of Oulu, Faculty of Medicine, Center for Life Course Health Research, Oulu, Finland 3MedEngine Oy, Helsinki, Finland 4Helsinki University Central Hospital, Department of Gastroenterology, Helsinki, Finland 5Turku University Central Hospital, Department of Gastroenterology, Turku, Finland 6Oulu University Hospital, Department of Gastroenterology, Oulu, Finland 7Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland 8Kuopio University Hospital, Department of Internal Medicine, Gastroenterology, Kuopio, Finland

P516: Adrenal suppression in inflammatory bowel disease patients treated with glucocorticoids: a systematic reviewECCO '17 Barcelona
Year: 2017
Authors:

Wood P.*1, Henderson P.1,2, Wilson D.1,2

1Royal Hospital For Sick Children, Department of Pediatric Gastroenterology, Edinburgh, United Kingdom 2University Of Edinburgh, Department of Child Life and Health, Edinburgh, United Kingdom

P517: Features of cytomegalovirus infection in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Makarchuk P., Belousova E., Volchkova E., Kudriavtseva E.

Moscow Regional Clinical Research Institute, Moscow, Russian Federation

P518: Remission induction in corticosteroid naïve children and adolescents with ulcerative colitis by adsorptive leucocytapheresis as monotherapy or in combination with low dose prednisolone after failure of first-line medicationsECCO '17 Barcelona
Year: 2017
Authors:

Tanaka T.*1, Goishi H.1, Kajihara T.1, Akagi M.1, Saniabadi A.2, Miura T.1

1Akitsu Hospital, Gastroenterology, Hiroshima, Japan 2JIMRO, Takasaki, Japan

P519: Anti-tumour necrosis-alpha therapy during pregnancy in patients with inflammatory bowel disease: safety in women and childrenECCO '17 Barcelona
Year: 2017
Authors:

Bernardes C., Loureiro R., Carvalho D., Borges V., Russo P., Saiote J., Ramos J.

Hospital de Sto Antόnio dos Capuchos, Gastroenterology, Lisbon, Portugal

P520: Perspective and self-efficacy of adolescents with inflammatory bowel disease post transition to adult careECCO '17 Barcelona
Year: 2017
Authors:

Yadav A., Forry M., O'Toole A., Patchett S.

Beaumont Hospital Dublin, Gastroenterology, Dublin, Ireland

P521: A prospective cohort study to assess the relevance of Vedolizumab drug level monitoring in IBD patientsECCO '17 Barcelona
Year: 2017
Authors:

Schulze H.*1, Esters P.1, Hartmann F.1, Stein J.2, Christ C.3, Zorn M.3, Dignass A.1

1Agaplesion Markus Hospital, Department of Medicine I, Frankfurt, Germany 2Interdisziplinäres Crohn Colitis Centrum, Frankfurt, Germany 3Immundiagnostik AG, Bensheim, Germany

P522: A multicenter study to validate Magnetic Resonance Enterography against histological assessments of stenotic disease in patients with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Coimbra A.*1, Rimola J.2, Cuatrecasas M.2, De Hertogh G.3, Van Assche G.3, Vanslembrouck R.3, Glerup H.4, Hedemann Nielsen A.4, Hagemann-Madsen R.4, Bouhnik Y.5, Zappa M.5, Cazals-Hatem D.5, D'Haens G.6, Stoker J.6, Meijer S.6, Rogler G.7, Boss A.7, Weber A.7, Zhao R.1, Keir M.1, Scherl A.1, deCrespigny A.1, Lu T.1, Panes J.2

1Genentech, Inc., South San Francisco, United States 2Hospital Clinic, Barcelona, Spain 3University Hospitals Leuven, Leuven, Belgium 4Regional Hospital Silkeborg, Silkeborg, Denmark 5Hospital Beaujon, Paris, France 6Academic Medical Center (AMC), Amsterdam, Netherlands 7University Hospital Zurich, Zurich, Switzerland

P523: Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naïve Crohn's disease: a subanalysis of DIAMOND trialECCO '17 Barcelona
Year: 2017
Authors:

Motoya S.*1, Nakase H.2, Matsumoto T.3, Watanabe K.4, Hisamatsu T.5, Yoshimura N.6, Ishida T.7, Kato S.8, Nakagawa T.9, Nagahori M.10, Esaki M.11, Matsui T.12, Naito Y.13, Kanai T.14, Suzuki Y.15, Nojima M.16, Watanabe M.10, Hibi T.17 the DIAMOND Study Group

1Sapporo Kosei General Hospital, Inflammatory Bowel Disease Centre, Sapporo, Japan 2Sapporo Medical University School of Medicine, Department of Gastroenterology and Hepatology, Sapporo, Japan 3Iwate Medical University, Division of Gastroenterology, Department of Medicine, Morioka, Japan 4Osaka City General Hospital, Division of Gastroenterology, Osaka, Japan 5Kyorin University School of Medicine, Department of Internal Medicine, Tokyo, Japan 6Tokyo Yamate Medical Centre, Department of Medicine, Division of Gastroenterology, Tokyo, Japan 7Oita Red Cross Hospital, Department of Gastroenterology, Oita, Japan 8Saitama Medical University Saitama Medical Centre, Department of Gastroenterology and Hepatology, Kawagoe, Japan 9Chiba University School of Medicine, Department of Gastroenterology and Nephrology, Chiba, Japan 10Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan 11Kyushu University Graduate School of Medical Sciences, Department of Medicine and Clinical Science, Fukuoka, Japan 12Fukuoka University Chikushi Hospital, Department of Gastroenterology, Chikushino, Japan 13Kyoto Prefectural University of Medicine, Department of Molecular Gastroenterology and Hepatology, Kyoto, Japan 14Keio University School of Medicine, Department of Internal Medicine, Tokyo, Japan 15Toho University Sakura Medical Centre, Department of Internal Medicine, Sakura, Japan 16University of Tokyo, Centre for Translational Research, Institute of Medical Science Hospital, Tokyo, Japan 17Kitasato University Kitasato Institute Hospital, Centre for Advanced IBD Research and Treatment, Tokyo, Japan

P524: Long-term outcomes after restorative proctocolectomy and ileal pouch-anal anastomosis in children compared to adultsECCO '17 Barcelona
Year: 2017
Authors:

Diederen K.*1, Sahami S.2, Tabbers M.1, Benninga M.1, Kindermann A.1, Tanis P.2, Oomen M.3, Bemelman W.2, de Jong J.3

1Dept. of Pediatric Gastroenterology and Nutrition, Academic Medical Center, Amsterdam, Netherlands 2Dept. of Surgery, Academic Medical Center, Amsterdam, Netherlands 3Dept. of Pediatric Surgery, Academic Medical Center, Amsterdam, Netherlands

P525: Effectiveness and safety of vedolizumab in IBD patients: a multicentre experience of “real world data” from the UKECCO '17 Barcelona
Year: 2017
Authors:

Lenti M.V.*1, Levison S.2, Eliadou E.2, Willert R.2, Kemp K.2, Stansfield C.3, Assadsangabi A.3, Singh S.4, Crooks B.4, Tattersall S.4, Kenneth C.5, Subramanian S.6, Probert C.6, Smith P.7, Liu E.7, Limdi J.K.8, Hamlin P.J.1, Selinger C.P.1

1Leeds Teaching Hospitals, Leeds Gastroenterology Institute, Leeds, United Kingdom 2Manchester Royal Infirmary - Central Manchester University Hospitals, Department of Gastroenterology, Manchester, United Kingdom 3Salford Royal NHS Foundation Trust, Department of Gastroenterology, Salford, United Kingdom 4Royal Bolton Hospital, Department of Gastroenterology, Bolton, United Kingdom 5Bradford Royal Infirmary, Teaching Hospitals, Department of Gastroenterology, Bradford, United Kingdom 6Royal Liverpool University Hospital, Department of Gastroenterology, Liverpool, United Kingdom 7Wrightington, Wigan and Leigh NHS Trust, Thomas Linacre Centre, Wigan, United Kingdom 8Pennine Acute Hospitals NHS Trust, Department of Gastroenterology, Manchester, United Kingdom

P526: A prospective 52-week mucosal healing and deep remission assessment of small bowel and colonic Crohn's disease as detected by colon capsule endoscopyECCO '17 Barcelona
Year: 2017
Authors:

Oliva S.*1, Cohen S.2, Civitelli F.1, Aloi M.1, Viola F.1, Casciani E.3, Maccioni F.4, Hassan C.5, Papoff P.6, Cucchiara S.1

1Sapienza - University of Rome, Department of Pediatrics, Pediatric Gastroenterology and Liver Unit, Rome, Italy 2Children's Center for Digestive Health Care, Atlanta, United States 3Sapienza - University of Rome, Department of Emergency Radiology, Rome, Italy 4Sapienza - University of Rome, Department of Radiological Sciences, Oncology, and Pathology, Rome, Italy 5Nuovo Regina Margherita Hospital, Gastroenterology Department, Rome, Italy 6Sapienza - University of Rome, Department of Pediatrics PICU, Rome, Italy

P527: Infliximab biosimilar switching program overseen by specialist pharmacist saves money, realises investment and optimises therapyECCO '17 Barcelona
Year: 2017
Authors:

St. Clair Jones A.*1, Smith M.2

1Brighton and Sussex University Hospitals NHS Trust, Department of Pharmacy, Brighton, United Kingdom 2Brighton and Sussex University Hospitals NHS Trust, Department of Gastroenterology, Brighton, United Kingdom